H.C. Wainwright & Co., LLC Strengthens Healthcare Equities Franchise with the Addition of Jim Horvath

NEW YORK--(BUSINESS WIRE)--H.C. Wainwright & Co., LLC (“HCW”), a leading investment bank focused on capital markets, equity research, and institutional sales across the life sciences and other high-growth sectors, today announced that Jim Horvath has joined the Firm as Managing Director and Healthcare Equities Sales Specialist.

Mr. Horvath brings more than 25 years of experience in institutional healthcare sales, with a proven track record of building and scaling high-impact sales platforms, expanding institutional coverage, and delivering differentiated access to healthcare research and corporate management teams. He most recently spent nearly a decade as a senior healthcare equities sales specialist at Piper Sandler, where he played a key part in strengthening the firm’s sales and distribution efforts.

At HCW, Mr. Horvath will be instrumental in building and expanding the Firm’s healthcare equities platform, leveraging his industry experience and institutional relationships to broaden coverage and distribution across the life sciences sector. Mr. Horvath brings deep industry knowledge and trusted relationships that immediately strengthen our healthcare equities platform and broaden our reach across the institutional investor community.

About H.C. Wainwright & Co.

H.C. Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. H.C. Wainwright & Co. also provides research and sales and trading services to institutional investors. According to EPFR, H.C. Wainwright’s team is ranked as the #1 Placement Agent in terms of aggregate CMPO (confidentially marketed public offering), RD (registered direct offering), and PIPE (private investment in public equity) executed cumulatively since 1998.

H.C. Wainwright & Co., LLC - MEMBER FINRA, SIPC